2021年欧洲心脏病学会心血管病预防临床实践指南解读

2021-12-15 西安交通大学第一附属医院心内科中华高血压杂志

2021年8月,新版欧洲心脏病学会（European Society of Cardiology,ESC）心血管病预防临床实践指南在ESC年会主会场颁布。

中文标题：

发布机构：

西安交通大学第一附属医院心内科

发布日期：

2021-12-15

简要介绍：

2021年8月,新版欧洲心脏病学会（European Society of Cardiology,ESC）心血管病预防临床实践指南在ESC年会主会场颁布。该指南由ESC、欧洲心脏病预防学会等13个学术组织专家组成的专家工作组共同制定^[1]。新指南在上一版指南（2016年颁布）^[2]基础上做了较大更新,更新部分主要围绕动脉粥样硬化性心血管病（arteriosclerotic cardiovascular disease,ASCVD）危险因素和风险评估、生活方式干预、危险因素管理、不同疾病风险管理四个部分进行论述,更新主要内容如下。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=89ff51c00235910e, title=2021年欧洲心脏病学会心血管病预防临床实践指南解读, enTitle=, guiderFrom=中华高血压杂志, authorId=0, author=, summary=2021年8月,新版欧洲心脏病学会（European Society of Cardiology,ESC）心血管病预防临床实践指南在ESC年会主会场颁布。, cover=https://img.medsci.cn/2022217/1645110101187_5579292.jpg, journalId=0, articlesId=null, associationId=2436, associationName=西安交通大学第一附属医院心内科, associationIntro=西安交通大学第一附属医院心内科, copyright=0, guiderPublishedTime=Wed Dec 15 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=2021年8月,新版欧洲心脏病学会（European Society of Cardiology,ESC）心血管病预防临床实践指南在ESC年会主会场颁布。该指南由ESC、欧洲心脏病预防学会等13个学术组织专家组成的专家工作组共同制定[1]。新指南在上一版指南（2016年颁布）[2]基础上做了较大更新,更新部分主要围绕动脉粥样硬化性心血管病（arteriosclerotic cardiovascular disease,ASCVD）危险因素和风险评估、生活方式干预、危险因素管理、不同疾病风险管理四个部分进行论述,更新主要内容如下。 , tagList=[TagDto(tagId=1849, tagName=心血管病)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4523, appHits=202, showAppHits=0, pcHits=591, showPcHits=4321, likes=0, shares=36, comments=5, approvalStatus=1, publishedTime=Fri Feb 18 15:38:00 CST 2022, publishedTimeString=2021-12-15, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Thu Feb 17 23:05:13 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 10:52:13 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021年欧洲心脏病学会心血管病预防临床实践指南解读.pdf)])

2021年欧洲心脏病学会心血管病预防临床实践指南解读.pdf

下载请点击：

评论区 (4)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1234490, encodeId=dd51123449075, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=083b4843400, createdName=775642037, createdTime=Sun Jul 24 22:16:11 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196747, encodeId=02601196e4763, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0eb2046086, createdName=1881eacd07m, createdTime=Thu Feb 24 10:50:50 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196397, encodeId=71d3119639e59, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9be6495931, createdName=ms8000000018254969, createdTime=Wed Feb 23 13:25:36 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194995, encodeId=202311949954a, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3e642424157, createdName=123a16c8m00暂无昵称, createdTime=Sat Feb 19 09:52:23 CST 2022, time=2022-02-19, status=1, ipAttribution=)]
2022-07-24 775642037

学习了

100 0 举报
[GetPortalCommentsPageByObjectIdResponse(id=1234490, encodeId=dd51123449075, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=083b4843400, createdName=775642037, createdTime=Sun Jul 24 22:16:11 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196747, encodeId=02601196e4763, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0eb2046086, createdName=1881eacd07m, createdTime=Thu Feb 24 10:50:50 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196397, encodeId=71d3119639e59, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9be6495931, createdName=ms8000000018254969, createdTime=Wed Feb 23 13:25:36 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194995, encodeId=202311949954a, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3e642424157, createdName=123a16c8m00暂无昵称, createdTime=Sat Feb 19 09:52:23 CST 2022, time=2022-02-19, status=1, ipAttribution=)]
2022-02-24 1881eacd07m

学习了

92 0 举报
[GetPortalCommentsPageByObjectIdResponse(id=1234490, encodeId=dd51123449075, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=083b4843400, createdName=775642037, createdTime=Sun Jul 24 22:16:11 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196747, encodeId=02601196e4763, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0eb2046086, createdName=1881eacd07m, createdTime=Thu Feb 24 10:50:50 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196397, encodeId=71d3119639e59, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9be6495931, createdName=ms8000000018254969, createdTime=Wed Feb 23 13:25:36 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194995, encodeId=202311949954a, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3e642424157, createdName=123a16c8m00暂无昵称, createdTime=Sat Feb 19 09:52:23 CST 2022, time=2022-02-19, status=1, ipAttribution=)]
2022-02-23 ms8000000018254969

学习

140 0 举报
[GetPortalCommentsPageByObjectIdResponse(id=1234490, encodeId=dd51123449075, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=083b4843400, createdName=775642037, createdTime=Sun Jul 24 22:16:11 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196747, encodeId=02601196e4763, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0eb2046086, createdName=1881eacd07m, createdTime=Thu Feb 24 10:50:50 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196397, encodeId=71d3119639e59, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9be6495931, createdName=ms8000000018254969, createdTime=Wed Feb 23 13:25:36 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194995, encodeId=202311949954a, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3e642424157, createdName=123a16c8m00暂无昵称, createdTime=Sat Feb 19 09:52:23 CST 2022, time=2022-02-19, status=1, ipAttribution=)]
2022-02-19 123a16c8m00暂无昵称

受益匪浅

100 0 举报

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

心血管指南

2021年欧洲心脏病学会心血管病预防临床实践指南解读

相关指南

科室

工具

服务